BE777911A - Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant - Google Patents

Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
BE777911A
BE777911A BE777911A BE777911A BE777911A BE 777911 A BE777911 A BE 777911A BE 777911 A BE777911 A BE 777911A BE 777911 A BE777911 A BE 777911A BE 777911 A BE777911 A BE 777911A
Authority
BE
Belgium
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
heterocyclic compounds
new heterocyclic
Prior art date
Application number
BE777911A
Other languages
English (en)
French (fr)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of BE777911A publication Critical patent/BE777911A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
BE777911A 1971-01-11 1972-01-11 Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant BE777911A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB4095971 1971-09-02
GB5646771 1971-12-06

Publications (1)

Publication Number Publication Date
BE777911A true BE777911A (fr) 1972-07-11

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
BE777911A BE777911A (fr) 1971-01-11 1972-01-11 Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant

Country Status (20)

Country Link
JP (1) JPS5531156B2 (da)
AR (1) AR192734A1 (da)
AT (1) AT312595B (da)
AU (1) AU464388B2 (da)
BE (1) BE777911A (da)
CA (1) CA1012150A (da)
CH (1) CH573938A5 (da)
CY (1) CY926A (da)
DK (1) DK150143C (da)
EG (1) EG10888A (da)
ES (2) ES398678A1 (da)
FI (1) FI54120C (da)
FR (1) FR2121699B1 (da)
GB (1) GB1366133A (da)
HK (1) HK52877A (da)
IE (1) IE35956B1 (da)
KE (1) KE2777A (da)
MY (1) MY7800048A (da)
NL (1) NL174251C (da)
SE (1) SE398645B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (ja) * 1977-06-06 1983-10-12 株式会社日立製作所 情報検索装置
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (ja) * 1984-03-28 1985-10-15 Casio Comput Co Ltd デ−タ記憶機能付小型電子機器
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
ES409296A1 (es) 1976-03-16
AU464388B2 (en) 1975-08-28
AR192734A1 (es) 1973-03-14
HK52877A (en) 1977-10-20
FR2121699A1 (da) 1972-08-25
FI54120B (fi) 1978-06-30
SE398645B (sv) 1978-01-09
KE2777A (en) 1977-10-21
FR2121699B1 (da) 1975-08-01
DK150143C (da) 1987-06-01
NL174251C (nl) 1984-05-16
CA1012150A (en) 1977-06-14
JPS5531156B2 (da) 1980-08-15
MY7800048A (en) 1978-12-31
NL7200415A (da) 1972-07-13
IE35956L (en) 1972-07-11
CH573938A5 (da) 1976-03-31
AT312595B (de) 1974-01-10
DK150143B (da) 1986-12-15
NL174251B (nl) 1983-12-16
ES398678A1 (es) 1975-05-16
AU3755872A (en) 1973-07-05
IE35956B1 (en) 1976-07-07
CY926A (en) 1977-12-23
FI54120C (fi) 1978-10-10
EG10888A (en) 1978-06-30
GB1366133A (en) 1974-09-11
JPS4839500A (da) 1973-06-09

Similar Documents

Publication Publication Date Title
BE801108A (fr) Nouveaux composes pyridopyrrolobenzheterocycliques leur preparation et compositions pharmaceutiques les contenant
BE771493A (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositionsqui les contiennent
BE826709A (fr) Nouveaux composes heterocycliques, leur preparation et medicament les contenant
BE778796A (fr) Derives des polymyxines, leur preparation et les compositions medicinales les contenant
BE853422A (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE764659A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
BE764660A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
FR2283686A1 (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant
BE783219A (fr) Nouveaux composes heterocycliques, leur preparation et leur applicationcomme medicaments
BE776682A (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositionsmedicinales qui les contiennent
BE800311A (fr) Aminohalopyridines substituees, leur preparation et compositions en contenant
BE777911A (fr) Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant
BE848227A (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant,
BE806854A (fr) Nouvelles urees tricycliques, leur preparation et les compositions pharmaceutiques en contenant
BE764998A (fr) Nouveaux composes heterocycliques antidiabetiques et leur preparation
BE803474A (fr) Nouvelles 2-alkylamino-dihydropyridines, leur procede de preparation et compositions pharmaceutiques les contenant
FR2290193A1 (fr) Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant
BE786031A (fr) Nouveaux derives de la phenanthridine, leur preparation et les compositions medicinales qui les contiennent
BE792079A (fr) Nouveaux composes insatures, leur preparation et leur application commemedicaments
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant
BE785398A (fr) Gonadotrophines presentant une activite prolongee, leur preparation et compositions pharmaceutiques les contenant
BE788609A (fr) Nouveaux derives de l'imidazole, leur preparation et les compositions medicinales qui les contiennent
BE761713A (fr) Nouvelles pyrrolidines substituees, leur preparation et compositions pharmaceutiques les contenant
BE773205A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
BE778564A (fr) Nouveaux esters d'ara-cytidine, leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: JOHN WYETH & BROTHER LTD

Effective date: 19900131